School of Medicine


Showing 11-20 of 54 Results

  • Risheen Reejhsinghani

    Risheen Reejhsinghani

    Clinical Assistant Professor, Medicine - Cardiovascular Medicine

    BioRisheen Reejhsinghani obtained her medical degree in Mumbai, India, followed by an internal medicine residency at St. Elizabeth's Medical Center in Boston, MA and cardiology fellowship at Baystate Medical Center/Tufts University School of Medicine, where she served as one of the chief fellows. She subsequently completed an advanced echocardiography fellowship at the University of California, San Francisco, and is board certified in echocardiography, general cardiology, and nuclear cardiology.

    Dr. Reejhsinghani practices as a general cardiologist in the Division of Cardiovascular Medicine at Stanford University School of Medicine, where she also serves as the associate director for the hospital-based consultative cardiology service. As a clinical cardiologist, she believes strongly in the tenets of evidence-based practice, diagnostic cognizance, and patient education. She also has a specific interest in the burgeoning field of Cardio-Rheumatology, focused on cardiac diseases among patients with rheumatologic conditions such as rheumatoid arthritis, systemic lupus erythematosus, scleroderma, and ankylosing spondylitis, among others. Her clinical research in this area has focused on the evaluation of structural cardiac disease and diastolic dysfunction in ankylosing spondylitis patients, primarily using echocardiography.

    Dr. Reejhsinghani has an academic focus in medical education, and believes that instilling a love for bedside medicine and the physical exam is the soundest way to empower future generations of learners. To this end, she received additional training in clinical teaching and simulation at the University of California, San Francisco, and has worked extensively on curriculum and course design. She currently serves as the associate program director of the cardiovascular medicine fellowship at Stanford, and is an associate course director for the Year 1 Practice of Medicine Course at the Stanford University medical school. Dr. Reejhsinghani also enjoys writing, particularly about medical education and has written articles for international newspapers, among other publications.

  • David Rehkopf

    David Rehkopf

    Associate Professor of Epidemiology and Population Health, of Medicine (Primary Care and Population Health) and, by courtesy, of Sociology

    BioI am a social epidemiologist and serve as an Associate Professor in the Department of Epidemiology and Population Health and in the Department of Medicine in the Division of Primary Care and Population Health. I joined the faculty at Stanford School of Medicine in 2011.

    I am currently the co-director of the Stanford Center for Population Health Sciences. In this position I am committed to making high value data resources available to researchers across disciplines in order to better enable them to answer their most pressing clinical and population health questions.

    My own research is focused on understanding the health implications of the myriad decisions that are made by corporations and governments every day - decisions that profoundly shape the social and economic worlds in which we live and work. While these changes are often invisible to us on a daily basis, these seemingly minor actions and decisions form structural nudges that can create better or worse health at a population level. My work demonstrates the health implications of corporate and governmental decisions that can give the public and policy makers evidence to support new strategies for promoting health and well-being. In all of his work, I have a focus on the implications of these exposures for health inequalities.

    Since often policy and programmatic changes can take decades to influence health, my work also includes more basic research in understanding biological signals that may act as early warning signs of systemic disease, in particular accelerated aging. I examine how social and economic policy changes influence a range of early markers of disease and aging, with a particular recent focus on DNA methylation. I am supported by several grants from the National Institute on Aging and the National Institute on Minority Health and Health Disparities to develop new more sensitive ways to understand the health implications of social and economic policy changes.

  • David A. Relman

    David A. Relman

    Thomas C. and Joan M. Merigan Professor and Professor of Microbiology and Immunology

    Current Research and Scholarly InterestsMy investigative program focuses on human-microbe interactions and human microbial ecology, and primarily concerns the ecology of human indigenous microbial communities; a secondary interest concerns the classification of humans with systemic infectious diseases, based on features of genome-wide gene transcript abundance patterns and pther aspects of the host response.

  • Andrew Rezvani, M.D.

    Andrew Rezvani, M.D.

    Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)

    Current Research and Scholarly InterestsClinical research in allogeneic hematopoietic cell transplantation

  • June-Wha Rhee

    June-Wha Rhee

    Instructor, Medicine
    Affiliate, Cardiovascular Institute Operations

    BioDr. Rhee is a general cardiologist with specialized clinical and research training in cardiovascular drug toxicity and pharmacogenomics. She completed clinical cardiology fellowship and internal medicine residency training at Stanford University School of Medicine. During her post-doctoral training, Dr. Rhee's research focused on elucidating cardiotoxic effects of iron overload and of multiple chemotherapeutic agents using patient-specific induced pluripotent stem cells (iPSCs) derived models. Her current research employs clinical data, population genomics, and patient-derived iPSCs models to study genetic determinants and mechanisms of drug-induced cardiovascular toxicities. Dr. Rhee's clinic sees cardio-oncology patients and focuses on devising new methods for minimizing cardiovascular complications in that population.

  • Fauzia Riaz, M.D., M.H.S.

    Fauzia Riaz, M.D., M.H.S.

    Clinical Assistant Professor, Medicine - Oncology

    BioDr. Riaz is a medical oncologist specializing in breast cancer whose research focuses on novel therapeutics and approaches cancer care delivery for patients with breast cancer. She is currently a Clinical Assistant Professor in the Department of Medicine at Stanford University School of Medicine. Dr. Riaz completed formal research training during her fellowship, through Yale University’s Advanced Health Sciences Research program. This included training in biostatistics, research methodology, and health policy, ultimately culminating in the completion of a Master of Health Sciences. As faculty, she is an active member of the Stanford Breast Oncology Clinical Research Group, and currently serves as the Stanford site principal investigator and sub-investigator for several ongoing breast cancer clinical trials.

  • Stephen Richmond

    Stephen Richmond

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    BioDr. Stephen Richmond is a family physician, educator, and heath justice advocate with specific interest in racial equity in medicine. He currently serves as a Clinical Assistant Professor of Medicine in the Stanford Division of Primary Care and Population Health. He completed his BA in Molecular & Cell Biology at UC Berkeley, MPH at Harvard T.H. Chan School of Public Health, and MD at David Geffen School of Medicine, UCLA. He is a graduate of the UCSF-SFGH Family & Community Medicine Residency Program. As a clinician, Dr. Richmond cares for individuals of all ages with a wide range of acute and chronic illnesses. He is especially passionate about providing high quality, evidenced-based care to underserved communities of color. As a researcher and educator, his interests broadly involve the intersection of race, racism, and medicine, with current projects focused on applications of Critical Race Theory to medical education and clinical care. He most recently served as the co-director of the Health Equity & Racial Justice Graduate Medical Education Pathway at UCSF and is presently involved in many ongoing advocacy efforts aimed at achieving structural change. Dr. Richmond has received multiple teaching awards for his work in the space of diversity, equity, inclusion & anti-oppression in medicine, and is a routine presenter and consultant in these areas.